SEVERE ANAPHYLACTOID REACTION AFTER IV GD-DTPA

被引:46
作者
WEISS, KL
机构
[1] Department of Radiology, Albert Einstein College of Medicine, Bronx
关键词
Allergy; Contrast; Gd-DTPA; MRI;
D O I
10.1016/0730-725X(90)90019-X
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Serious adverse reactions following the IV administration of Gd-DTPA (Magnevist®, gadopenetate dimeglumine, Berlex Laboratories, Wayne, NJ), although extremely rare, can occur. As yet, there has been no published case of a severe anaphylactoid-type reaction to Gd-DTPA. © 1990.
引用
收藏
页码:817 / 818
页数:2
相关论文
共 7 条
  • [1] Berlex Laboratories, Magnevist product insert, (1989)
  • [2] Chan, Bosanko, Wang, Pruritus and parasthesia after IV administration of Gd-DTPA, AJNR, 10, (1989)
  • [3] Goldstein, Kashanian, Blumetti, Holyoak, Hugo, Blumenfield, Safety assessment of gadopenetate dimeglumine in U.S. clinical trials, Radiology, 174, pp. 17-23, (1990)
  • [4] LaFlore, Goldstein, Rogan, Keelan, Ewell, A prospective evaluation of adverse experiences following the administration of Magnevist (Gd-DTPA) injection, Abstract-Works in progress, (1989)
  • [5] Wolf, Current status of MR imaging contrast agent: Special report, Radiology, 172, pp. 709-710, (1989)
  • [6] Youlten, Allergy practice forum-drug induced anaphylaxis, Clin. Exp. Allergy, 19, pp. 233-235, (1989)
  • [7] Lasser, Pretreatment with corticosteroids to prevent reactions to i.v. contrast material: overview and implications, American Journal of Roentgenology, 150, pp. 257-259, (1988)